Ticker Report VectivBio Holding AG (NASDAQ:VECT Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 77,600 shares, a decrease of 21.3% from the May 31st total of 98,600 shares. Based on an average daily ...\n more…
Business Wire Ironwood Pharmaceuticals, Inc. (Ironwood) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, today...\n more…
Globe Newswire BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, announced that today's extraordinary general meeting ...\n more…
PR Newswire ALERT: The M&A Class Action Firm Continues Investigating the Merger - VECT, MYBF, CHRA, HMPT ALERT: The M&A Class Action Firm Continues Investigating the Merger - VECT, MYBF, CHRA, HMPT PR Newswire NEW YORK, June 17, 2023 NEW YORK, June 17, 2023 /PRNewswire/ -- Juan Monteverde...\n more…
Business Wire Ironwood Pharmaceuticals, Inc. (Ironwood) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, today...\n more…
Globe Newswire NEW YORK, June 14, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the M&A Class Action Firm), a national securities firm ratedTop 50in the 2018-2021 ISS Securities Class Action Services Report and headquartered at theEmpire...\n more…